EL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Estée Lauder is not a strong buy right now for a Beginner investor focused on long-term holding, especially with $50,000-$100,000 and no need to chase an entry. The stock has improved operationally and sentiment has turned more constructive, but the current setup is mixed: price is only slightly above the previous close, momentum is positive but stretched, insider selling is elevated, and the short-term pattern points to weakness. My direct view is to hold off on buying today and wait for a better long-term entry after clearer confirmation of sustained recovery.
EL is in a modest rebound phase rather than a clean breakout trend. MACD histogram is positive and expanding, which supports near-term upside momentum. However, RSI_6 at 72.658 shows the stock is getting stretched, and moving averages are converging, which suggests the trend is not yet firmly established. Price at 91 is just above pivot 83.584 and near resistance 90.11, with the next resistance at 94.142. The stock trend model also points to downside bias over the next 1 day, 1 week, and 1 month, which weakens the case for an immediate buy.
["Piper Sandler initiated coverage with an Overweight rating and a $95 target.", "Multiple analysts raised targets after Q3 results, showing improving confidence.", "Q3 showed organic growth in three of four geographic regions.", "Americas showed stabilization with improving channel mix and benefits from the Profit Recovery & Growth Program.", "Management guidance implies further top-line inflection in FY27.", "Est\u00e9e Lauder abandoned merger talks with Puig, which analysts viewed as prudent and which the market reacted to positively.", "Congress trading data is supportive, with 4 purchase transactions versus only 1 sale in the last 90 days."]
["Insiders are selling heavily, and selling has increased sharply over the last month.", "Short-term stock pattern analysis suggests downside over the next day, week, and month.", "RSI is elevated, indicating the stock may be somewhat overextended near term.", "Analysts remain mixed, with several Neutral/Equal Weight ratings despite higher price targets.", "There is still concern around the turnaround timeline, especially China, travel retail, and broader market-share recovery.", "Potential Puig transaction complexity has been a concern in parts of the analyst commentary."]
Latest quarter information available is Q3 FY2026. The quarter was described as constructive and better than expected, with organic sales growth, stronger sales, gross margin leverage, and continued cost discipline. Management also pointed to share gains in Mainland China, growth across product categories, and ongoing operational efficiency improvements. However, the company still needs sustained recovery in China and travel retail before the turnaround is fully convincing.
Analyst sentiment has improved recently, with several firms raising price targets after Q3. Piper Sandler initiated at Overweight with a $95 target, Deutsche Bank remains Buy at $108, and JPMorgan is Overweight at $99. At the same time, Barclays, UBS, Morgan Stanley, Telsey, B. Riley, Wells Fargo, and Canaccord are mostly Neutral/Equal Weight/Hold, showing a split Wall Street view. The pros case is that the turnaround is gaining traction and valuation has reset lower; the cons case is that visibility is still limited and the recovery may take time.
